Evaluation of a whole body vibration training on physical and psychological parameters of breast cancer patients with chemotherapy-induced peripheral neuropathy

Not Applicable

Recruiting

• Conditions: C50; G62; Malignant neoplasm of breast; Other polyneuropathies

• Registration Number: DRKS00018797
• Lead Sponsor: Krebszentrum NordUKSH, Campus Kiel

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-11-06
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Beginning of a chemotherapy treatment with cisplatin, paclitaxel or vinca alkaloids

Exclusion Criteria

acute infectious diseases, severe cardiac diseases (e.g. NYHA 3, myocardial infarction <3 months), severe pulmonary insufficiency, renal insufficiency (GF <30% with creatinine >3mg/d), severe neurological disorders, longstanding diabetes with neurological involvement, alcohol consumption with neurological sequelae, presence or suspected presence of a Korsakov syndrome, intended radiotherapy during the intervention

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptomatic reduction of a chemotherapy-induced peripheral neuropathy

Secondary Outcome Measures

Name	Time	Method
Balance, strength, quality of life, fatigue, depth sensitivity